Autoantibodies against complement C1q in acute post-streptococcal glomerulonephritis

Clinical Immunology

Volumn 128, Issue 3, 2008, Pages 409-414

  Kozyro, Ina ^a   Korosteleva, Ludmila ^b   Chernoshej, Dmitryj ^a   Danner, Doris ^c   Sukalo, Alexander ^a   Trendelenburg, Marten ^c  

^a BELARUSIAN STATE UNIVERSITY   (Belarus)

^b Republic Centre of Oncohematology   (Belarus)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

APSGN; Autoantibody; Complement; Glomerulonephritis

Indexed keywords

AUTOANTIBODY; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CREATININE;

ADOLESCENT; ALLERGIC GLOMERULONEPHRITIS; ANTIBODY TITER; ARTICLE; CHILD; CLINICAL ARTICLE; COMPLEMENT BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE COURSE; FEMALE; HUMAN; HYPERTENSION; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; OLIGURIA; PRIORITY JOURNAL; PROTEINURIA;

ACUTE DISEASE; ADOLESCENT; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; COMPLEMENT C1Q; COMPLEMENT C3; COMPLEMENT C4; CREATININE; FEMALE; GLOMERULONEPHRITIS; HUMANS; MALE; PROTEINURIA; STREPTOCOCCAL INFECTIONS;

EID: 49349095081     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2008.04.005     Document Type: Article

References (48)

1. Prohaszka Z., Daha M.R., Susal C., et al. C1q autoantibodies in HIV infection: correlation to elevated levels of autoantibodies against 60-kDa heat-shock proteins. Clin. Immunol. 90 (1999) 247-255
2. Siegert C.E., Daha M.R., Halma C., van der Voort E.A., and Breedveld F.C. IgG and IgA autoantibodies to C1q in systemic and renal diseases. Clin. Exp. Rheumatol. 10 (1992) 19-23
3. Wener M.H., Uwatoko S., and Mannik M. Antibodies to the collagen-like region of C1q in sera of patients with autoimmune rheumatic diseases. Arthritis Rheum. 32 (1989) 544-551
4. Wisnieski J.J., and Jones S.M. IgG autoantibodies to the collagen-like region of C1q in hypocomplementemic urticarial vasculitis syndrome, systemic lupus erythematosus and six other skeletal or rheumatic diseases. J. Rheumatol. 19 (1992) 884-888
5. Wisnieski J.J., Baer A.N., Christensen J., et al. Hypocomplementemic Urticarial Vasculitis Syndrome. Clinical and serological findings in 18 patients. Medicine (Baltimore) 74 (1995) 24-41
6. Marto N., Bertolaccini M.L., Calabuig E., Hughes G.R., and Khamashta M.A. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus. Ann. Rheum. Dis. 29 (2004) [Electronic publication ahead of print]
7. Moroni G., Trendelenburg M., Del Papa N., et al. Anti-C1q antibodies may help in diagnosing renal flare in lupus nephritis. Am. J. Kidney Dis. 37 (2001) 490-498
8. Siegert C., Daha M., Westedt M.L., van der Voort E., and Breedveld F. IgG autoantibodies against C1q are correlated with nephritis, hypocomplementemia, and dsDNA antibodies in systemic lupus erythematosus. J. Rheumatol. 18 (1991) 230-234
9. Siegert C.E., Kazatchkine M.D., Sjoholm A., Wurzner R., Loos M., and Daha M.R. Autoantibodies against C1q: view on clinical relevance and pathogenic role. Clin. Exp. Immunol. 116 (1999) 4-8
10. Trendelenburg M., Marfurt J., Gerber I., Tyndall A., and Schifferli J.A. Lack of occurrence of severe lupus nephritis among anti-C1q autoantibody negative patients. Arthritis Rheum. 42 (1999) 187-188
11. Trendelenburg M., Lopez-Trascasa M., Potlukova E., Moll S., Regenass S., Frémeaux-Bacchi V., Martinez-Ara J., Jancova E., Picazo M.L., Honsova E., Tesar V., Sadallah S., and Schifferli J. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis. Neprol. Dial. Transplant. 21 (2006) 3115-3121
12. Sjoholm A.G., Martensson U., and Sturfelt G. Serial analysis of autoantibody responses to the collagen-like region of C1q, collagen type II, and double-stranded DNA in patients with systemic lupus erythematosus. J. Rheumatol. 24 (1997) 871-878.
13. Siegert C.E., Daha M.R., Tseng C.M., Coremans I.E., van Es L.A., and Breedveld F.C. Predictive value of IgG autoantibodies against C1q for nephritis in systemic lupus erythematosus. Ann. Rheum. Dis. 52 (1993) 851-856
14. Ronnelid J., Huang Y.H., Norrlander T., et al. Short-term kinetics of the humoral anti-C1q response in SLE using ELISPOT method: fast decline in production in response to steroids. Scand J. Immunol. 40 (1994) 243-250
15. Coremans I.E., Spronk P.E., Bootsma H., et al. Changes in antibodies to C1q predict renal relapses in systemic lupus erythematosus. Am. J. Kidney Dis. 26 (1995) 595-601
16. Haseley L.A., Wisnieski J.J., Denburg M.R., et al. Antibodies to C1q in systemic lupus erythematosus: chracteristics and relation to FcRIIA alleles. Kidney Int. 52 (1997) 1375-1380
17. Trouw L.A., Groeneveld T.W.L., Seelen M.A., et al. Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes. J. Clin. Invest. 114 (2004) 679-688
18. Kozyro I., Perahud I., Sadallah S., Sudalo A., Titov L., Schifferli J.A., and Trendelenburg M. Clinical value of autoantibodies against C1q in children with glomerulonephritis. Pediatrics 117 (2006) 1663-1668
19. Rodriguez-Iturbe B., and Batsford S. Pathogenesis of poststreptococcal glomerulonephritis a century after Clemens von Pirquet. Kidney Int. 71 (2007) 1094-1104
20. Nordstrand A., Norgren M., and Holm S.E. Pathogenic mechanism of acute post-streptococcal glomerulonephritis. Scand J. Infect. Dis. 31 (1999) 523-537
21. Ito S., Kuriyama H., Iino N., et al. Patient with diffuse mesangial and endocapillary proliferative glomerulonephritis with hypocomplementemia and elevated anti-streptolysin O tretaed with prednisolone, angiotensin-converting enzyme inhibitor, and angiotensin II receptor antagonist. Clin. Exp. Nephrol. 7 (2003) 290-295
22. Koroleva I.V., Sjöholm A.G., and Schalen C. Binding of complement subcomponent C1q to Streptococcus pyogenes: evidence for interactions with The M5 and FcRA76 proteins. FEMS Immunol. Med. Microbiol. 20 (1998) 11-20
23. Berge A., Kihlberg B.M., Sjöholm A.G., and Björck L. Streptococcal protein H forms soluble complement-activating complexes with IgG, but inhibits complement activation by IgG-coated targets. J. Biol. Chem. 272 (1997) 20774-20781
24. Oda T., Yamakami K., Omasu F., Suzuki S., Miura S., Sugisaki T., and Yoshizawa N. Glomerular plasmin-like activity in relation to nephritis-associated plasmin receptor in acute poststreptococcal glomerulonephritis. J. Am. Soc. Nephrol. 16 (2005) 247-254
25. Yoshizawa N., Yamakami K., Fujino M., Oda T., Tamura K., Matsumoto K., and Sugisaki T. Boule MDP: nephritis-associated plasmin receptor and acute glomerulonephritis: characterization of the antigen and associated immune response. J. Am. Soc. Nephrol. 15 (2004) 1785-1793
26. Poon-King R., Bannan J., Viteri A., Cu G., and Zabriskie J.B. Identification of an extracellular plasmin biding protein from nephritogenic streptococci. J. Exp. Med. 178 (1993) 759-763
27. Parra G., Rodríguez-Iturbe B., Batsford S., Vogt A., Mezzano S., Olavarría F., Exeni R., Lasso M., and Orta N. Antibody to streptococcal zymogen in the serum of patients with acute glomerulonephritis: a multicentric study. Kidney Int. 54 (1998) 509-517
28. Cu G.A., Mezzano S., Bannan J.D., and Zabriskie J.D. Immunohistochemical and serological evidence for the role of streptococcal proteinase in acute poststreptococcal glomerulonephritis. Kidney Int. 54 (1998) 819-826
29. Yamakami K., Yoshizawa N., wakabayashi Y., Takeuchi A., Tadakuma T., and Boyle M.D. The potential role for nephritis-associated plasmin receptor in acute poststreptococcal glomerulonephritis. Methods 1 (2002) 185-197
30. Batsford S.R., Mezzano S., Mihatsch M., Schiltz E., and Rodriguez-Iturbe B. Is the nephritogenic antigen in post-streptococcal glomerulonephritis pyrogenic exotoxin B (SPE B) or GAPDH?. Kidney Int. 68 (2005) 1120-1129
31. Von Zabern I. Action of polyionic substances on the complement system. In: Sim R.B. (Ed). Activators and Inhibitors of Complement (1993), Kluwer Academic Publishers, Boston 149-165
32. Kohro-Kawata J., Wener M.H., and Mannik M. The effect of high salt concentration on detection of serum immune complexes and autoantibodies to C1q in patients with sytemic lupus erythematosus. J. Rheumatol. 29 (2002) 84-89
33. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum. 40 (1997) 1725
34. Frémeaux-Bacchi V., Noel L.H., and Schifferli J.A. No lupus nephritis in the absence of antiC1q autoantibodies?. Nephrol. Dial. Transplant. 17 (2002) 2041-2043
35. Trendelenburg M. Antibodies against C1q in patients with systemic lupus erythematosus. Springer Semin. Immunopathol. 27 (2005) 279-285
36. Flierman R., and Daha M. Pathogenic role of anti-C1q autoantibodies in the development of lupus nephritis - a hypothesis. Mol. Immunol. 44 (2007) 133-138
37. Wyatt R.J., Forristal J., West C.D., Sugimoto S., and Curd J.G. Complement profiles in acute post-streptococcal glomerulonephritis. Pediatr. Nephrol. 2 (1988) 219-223
38. Sjoholm A.G. Complement components and complement activation in acute poststreptococcal glomerulonephritis. Int. Arch. Allergy Appl. Immunol. 58 (1979) 274-284
39. Potter E.V., Lipschultz S.A., Abidh S., et al. Twelve to seventeen-year follow-up of patients with poststreptococcal acute glomerulonephritis in Trinidad. N. Engl. J. Med. 307 (1982) 725-729
40. Roy III S., Murphy W.M., and Arant Jr. B.S. Poststreptococcal crescenteric glomerulonephritis in children: comparison of quintuple therapy versus supportive care. J. Pediatr. 98 (1981) 403-410
41. Lewy J.E., Salinas-Madrigal L., Herdson P.B., et al. Clinico-pathologic correlations in acute poststreptococcal glomerulonephritis: a correlation between renal functions, morphologic damage, and clinical course of 46 children with acute poststreptococcal glomerulonephritis. Medicine (Baltimore) 50 (1971) 453-501
42. Popović-Rolović M., Kostić M., Antić-Peco A., Jovanović O., and Popović D. Medium- and long-term prognosis of patients with acute poststreptococcal glomerulonephritis. Nephron 58 (1991) 393-399
43. Pinto S.W., Sesso R., Vasconcelos E., Watanabe Y.J., and Pansute A.M. Follow-up of patients with epidemic poststreptococcal glomerulonephritis. Am. J. Kidney Dis. 38 (2001) 249-255
44. Lien J.W., Mathew T.H., and Meadows R. Acute post-streptococcal glomerulonephritis in adults: a long-term study. Q. J. Med. 48 (1979) 99-111
45. Tejani A., and Ingulli E. Poststreptococcal glomerulonephritis. Current clinical and pathologic concepts. Nephron 55 (1990) 1-5
46. Prada A.E., and Strife C.F. IgG subclass restriction of autoantibody to solid-phase C1q in membranoproliferative and lupus glomerulonephritis. Clin. Immunol. Immunopathol 63 (1992) 84-88
47. Strife C.F., Leahy A.E., and West C.D. Antibody to a cryptic, swolid phase C1q antigen in membranoproliferative nephritis. Kidney Int. 35 (1989) 836-842
48. Neugarten J., and Baldwin D.S. Glomerulonephritis in bacterial endocarditis. Am. J. Med. 77 (1984) 297-304